| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
DURECT Corporation (STU: DC8)
DC8 Technical Analysis
5
| As on 17th Apr 2023 DC8 STOCK Price closed @ 4.18 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.64 & Strong Buy for SHORT-TERM with Stoploss of 0.95 we also expect STOCK to react on Following IMPORTANT LEVELS. |
DC8STOCK Price
| Open | 4.06 | Change | Price | % |
| High | 4.18 | 1 Day | 0.02 | 0.48 |
| Low | 4.06 | 1 Week | 0.22 | 5.56 |
| Close | 4.18 | 1 Month | -0.70 | -14.34 |
| Volume | N/A | 1 Year | 3.10 | 287.04 |
| 52 Week High 6.84 | 52 Week Low 0.34 | ||||
STU Germany Most Active Stocks
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| BT81 | 0.01 | 0.00% |
| BT81 | 0.01 | 0.00% |
| TINC | 0.01 | -1.50% |
| D7G | 0.20 | 11.11% |
| D7G | 0.20 | 11.11% |
STU Germany Top Gainers Stocks
STU Germany Top Losers Stocks
| DC8 Daily Charts |
DC8 Intraday Charts |
Whats New @ Bazaartrend |
DC8 Free Analysis |
|
|
DC8 Important Levels Intraday
| RESISTANCE | 4.41 |
| RESISTANCE | 4.34 |
| RESISTANCE | 4.29 |
| RESISTANCE | 4.25 |
| SUPPORT | 4.11 |
| SUPPORT | 4.07 |
| SUPPORT | 4.02 |
| SUPPORT | 3.95 |
DC8 Forecast March 2025
| 4th UP Forecast | 4.55 |
| 3rd UP Forecast | 4.43 |
| 2nd UP Forecast | 4.36 |
| 1st UP Forecast | 4.28 |
| 1st DOWN Forecast | 4.08 |
| 2nd DOWN Forecast | 4 |
| 3rd DOWN Forecast | 3.93 |
| 4th DOWN Forecast | 3.81 |
DC8 Weekly Forecast
| 4th UP Forecast | 4.33 |
| 3rd UP Forecast | 4.28 |
| 2nd UP Forecast | 4.25 |
| 1st UP Forecast | 4.22 |
| 1st DOWN Forecast | 4.14 |
| 2nd DOWN Forecast | 4.11 |
| 3rd DOWN Forecast | 4.08 |
| 4th DOWN Forecast | 4.03 |
DC8 Forecast2025
| 4th UP Forecast | 16.71 |
| 3rd UP Forecast | 12.69 |
| 2nd UP Forecast | 10.21 |
| 1st UP Forecast | 7.72 |
| 1st DOWN Forecast | 0.64 |
| 2nd DOWN Forecast | -1.85 |
| 3rd DOWN Forecast | -4.33 |
| 4th DOWN Forecast | -8.35 |
DURECT Corporation ( STU Germany Symbol : DC8 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
DC8 Business Profile
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops DUR-928, an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid homeostasis, inflammation, and cell survival, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine up to days of in adults. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; Santen Pharmaceutical Co., Ltd.; Sandoz AG; and Gilead Sciences, Inc. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California. Address: 10260 Bubb Road, Cupertino, CA, United States, 95014-4166
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service